NFKB inhibitor alpha
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The NFKBIA gene provides instructions for making one piece (the alpha subunit) of the IKK protein complex, which is a group of related proteins that regulates the activity of nuclear factor-kappa-B. Nuclear factor-kappa-B is a protein complex that binds to DNA and controls the activity of other genes. When it is turned off (inactive), nuclear factor-kappa-B is attached (bound) to the IKK complex. In response to certain signals, the IKK complex turns on (activates) nuclear factor-kappa-B and releases it.
Video picks for GenesVideo library
Normal function
The NFKBIA gene provides instructions for making one piece (the alpha subunit) of the IKK protein complex, which is a group of related proteins that regulates the activity of nuclear factor-kappa-B. Nuclear factor-kappa-B is a protein complex that binds to DNA and controls the activity of other genes. When it is turned off (inactive), nuclear factor-kappa-B is attached (bound) to the IKK complex. In response to certain signals, the IKK complex turns on (activates) nuclear factor-kappa-B and releases it.
The NFKBIA protein helps keep nuclear factor-kappa-B bound in the IKK complex. When the NFKBIA protein receives a signal that nuclear factor-kappa-B is to be released, it breaks down so the factor can be turned on (activated) and released from the complex. Once the active factor is released, it moves into the nucleus and binds to DNA. Nuclear factor-kappa-B regulates the activity of multiple genes, including genes that control the body's immune responses and inflammatory reactions. Nuclear factor-kappa-B also appears to play a role in the signaling pathway that is critical for the formation of ectodermal tissues including the skin, hair, teeth, and sweat glands. In addition, it protects the cell from certain signals that would otherwise cause it to self-destruct (undergo apoptosis).
Conditions referring to this gene or chromosome
Other names
I-kappa-B-alpha
IkappaBalpha
ikB-alpha
IKBA
IKBA_HUMAN
MAD-3
major histocompatibility complex enhancer-binding protein MAD3
NF-kappa-B inhibitor alpha
NFKBI
nuclear factor of kappa light chain gene enhancer in B-cells
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
Patient picks for Genes

Treatment and medication
Alpha-blockers
Alpha-blockers are medicines that are mainly used to treat high blood pressure (hypertension) and problems with passing urine in men who have enlargement of the prostate gland. Prostate gland enlargement is also called benign prostatic hyperplasia (BPH).
by Dr Doug McKechnie, MRCGP

Treatment and medication
ACE inhibitors
ACE inhibitors are medicines that are used mainly in the treatment of high blood pressure (hypertension) and heart failure. They are also used in some people with diabetes, for some forms of kidney disease, and after a heart attack, to help protect the heart. They have a variety of effects on the body. Their ability to relax blood vessels is one of the most important. The side-effects most commonly associated with ACE inhibitors are usually minor. A common side-effect is a persistent dry cough.
by Dr Toni Hazell, FRCGP

Children's health
Alpha-1 antitrypsin deficiency
Alpha-1 antitrypsin deficiency is an inherited genetic condition. A genetic condition is one that can be passed on from parents through genes. In alpha-1 antitrypsin deficiency the result of a genetic abnormality leads to lung and, in some people, liver damage. Lung symptoms are the most common and include shortness of breath, cough and wheezing. Symptoms can worsen over time. At present, there is no cure for alpha-1 antitrypsin deficiency. Treatment aims at slowing down the progression of the disease.
by Dr Philippa Vincent, MRCGP

Treatment and medication
Proton pump inhibitors
Proton pump inhibitors reduce the amount of acid made by the stomach. They are commonly used to treat acid reflux and ulcers of the stomach and part of the gut called the duodenum. Most people who take a proton pump inhibitor do not develop any side-effects.
by Dr Philippa Vincent, MRCGP

Medicine
Phenoxybenzamine - an alpha-blocker
Adults will normally start with one capsule a day. This dose may then be increased over the next few days. It is common to feel dizzy or light-headed initially. This should soon settle. You may be given other medicines to take alongside phenoxybenzamine.
by Michael Stewart, MRPharmS

Medicine
Prazosin - an alpha-blocker
Your first dose of prazosin may make you feel dizzy or faint, or start sweating. Take your first dose at bedtime and remain lying down until these symptoms have completely passed. Prazosin can cause dizziness which may affect your ability to drive. Make sure your reactions are normal before you drive and before you use tools or machines.
by Michael Stewart, MRPharmS
Related patient information and medicines

Patient information leaflet
Ankylosing spondylitis
Ankylosing spondylitis is an auto-immune disease. It is not known exactly why ankylosing spondylitis occurs but there is a ge... In ankylosing spondylitis, a chemical called cytokine tumour necrosis factor alpha (TNF-alpha) is involved in causing inflammation. In the UK the National Institute for Health and Care Excellence (NICE) recommends that.

Patient information leaflet
Psoriatic arthritis
The National Institute for Health and Care Excellence (NICE) guidelines advise that etanercept, infliximab, adalimumab or golimumab should be offered as an option for treating adults with psoriatic arthritis when: The person has arthritis with three or more tender joints and three or more swollen joints; and When at least two other DMARDs, given.

Patient information leaflet
High blood pressure
High blood pressure (hypertension) happens when the force on the walls of blood vessels (caused by the blood within them) is more than normal. ...vessels (caused by the blood within them) is more than normalHealthcare professionals sometimes call high blood pressure 'hypertension'..

Patient information leaflet
Mitral regurgitation
The mitral valve is a heart valve that lies between the left atrium and left ventricle. ...eart - mitral valve incompetence i88_l.jpg What is mitral regurgitationAlthough medicines cannot correct mitral regurgitation, some medicines may be prescribed to help ease symptoms, or to help prevent complications by managing your blood pressure - for.

Patient information leaflet
Medicine for high blood pressure
For detailed information about your own medication you should read the leaflet that comes inside the medicine packet. What are the types of blood pressure medicines. There are six main classes of medicines that are used to lower blood pressure: Angiotensin-converting enzyme (ACE) inhibitors. Alpha blockers Alpha blockers are usually added in to.

Patient information leaflet
Parkinson's disease
Diagnosing Parkinson's disease is based on symptoms. If your GP suspects that you may have Parkinson's disease, you will be referred to a neurology specialist. You will likely have some tests in hospital to rule out other causes of your symptoms, such as ... Surgery may be an option for severe cases. The National Institute for Health and Care.
Further reading and references
- NFKB inhibitor alpha; MedlinePlus, National Library of Medicine.
- Courtois G, Smahi A, Reichenbach J, Doffinger R, Cancrini C, Bonnet M, Puel A, Chable-Bessia C, Yamaoka S, Feinberg J, Dupuis-Girod S, Bodemer C, Livadiotti S, Novelli F, Rossi P, Fischer A, Israel A, Munnich A, Le Deist F, Casanova JL. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest. 2003 Oct;112(7):1108-15. doi: 10.1172/JCI18714.
- Kawai T, Nishikomori R, Heike T. Diagnosis and treatment in anhidrotic ectodermal dysplasia with immunodeficiency. Allergol Int. 2012 Jun;61(2):207-17. doi: 10.2332/allergolint.12-RAI-0446.
- McDonald DR, Mooster JL, Reddy M, Bawle E, Secord E, Geha RS. Heterozygous N-terminal deletion of IkappaBalpha results in functional nuclear factor kappaB haploinsufficiency, ectodermal dysplasia, and immune deficiency. J Allergy Clin Immunol. 2007 Oct;120(4):900-7. doi: 10.1016/j.jaci.2007.08.035.
- Puel A, Picard C, Ku CL, Smahi A, Casanova JL. Inherited disorders of NF-kappaB-mediated immunity in man. Curr Opin Immunol. 2004 Feb;16(1):34-41. doi: 10.1016/j.coi.2003.11.013.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

